These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 23648086)

  • 41. Epigenetic basis of the dark side of alcohol addiction.
    Pandey SC; Kyzar EJ; Zhang H
    Neuropharmacology; 2017 Aug; 122():74-84. PubMed ID: 28174112
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rational development of addiction pharmacotherapies: successes, failures, and prospects.
    Pierce RC; O'Brien CP; Kenny PJ; Vanderschuren LJ
    Cold Spring Harb Perspect Med; 2012 Jun; 2(6):a012880. PubMed ID: 22675669
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of the neuropeptide S system in addiction: focus on its interaction with the CRF and hypocretin/orexin neurotransmission.
    Cannella N; Kallupi M; Ruggeri B; Ciccocioppo R; Ubaldi M
    Prog Neurobiol; 2013 Jan; 100():48-59. PubMed ID: 23041581
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Improving the old, embracing the new: implications of alcohol research for future practice.
    Gordis E
    Soc Work Health Care; 2001; 33(1):17-41. PubMed ID: 11718535
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neurobiology of an endophenotype: modeling the progression of alcohol addiction in rodents.
    Mahoney MK; Olmstead MC
    Curr Opin Neurobiol; 2013 Aug; 23(4):607-14. PubMed ID: 23541596
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hypothalamic neuropeptide signaling in alcohol addiction.
    Barson JR; Leibowitz SF
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Feb; 65():321-9. PubMed ID: 25689818
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gene coexpression networks in human brain identify epigenetic modifications in alcohol dependence.
    Ponomarev I; Wang S; Zhang L; Harris RA; Mayfield RD
    J Neurosci; 2012 Feb; 32(5):1884-97. PubMed ID: 22302827
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacological approaches to the management of alcohol addiction.
    Addolorato G; Armuzzi A; Gasbarrini G; De Lorenzi G; Ancona C; Abenavoli L; Parente A; Leggio L; Capristo E; Greco AV; Janiri L; Pozzi G; Taranto C; Caputo F; Bernardi M; Stefanini GF; Foschi FG;
    Eur Rev Med Pharmacol Sci; 2002; 6(5):89-97. PubMed ID: 12776801
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Appetite- and volume-regulating neuropeptides: Role in treating alcohol dependence.
    Hillemacher T; Kahl KG; Heberlein A; Muschler MA; Eberlein C; Frieling H; Bleich S
    Curr Opin Investig Drugs; 2010 Oct; 11(10):1097-106. PubMed ID: 20872312
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neuropharmacological treatments for alcoholism: scientific basis and clinical findings.
    Johnson BA; Ait-Daoud N
    Psychopharmacology (Berl); 2000 May; 149(4):327-44. PubMed ID: 10867960
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neuropeptides: general characteristics and neuropharmaceutical potential in treating CNS disorders.
    Strand FL
    Prog Drug Res; 2003; 61():1-37. PubMed ID: 14674607
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Integrative Analysis of Genetic, Genomic, and Phenotypic Data for Ethanol Behaviors: A Network-Based Pipeline for Identifying Mechanisms and Potential Drug Targets.
    Bogenpohl JW; Mignogna KM; Smith ML; Miles MF
    Methods Mol Biol; 2017; 1488():531-549. PubMed ID: 27933543
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacogenomics of alcohol response and addiction.
    Enoch MA
    Am J Pharmacogenomics; 2003; 3(4):217-32. PubMed ID: 12930156
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Recent advances in the development of treatments for alcohol and cocaine dependence: focus on topiramate and other modulators of GABA or glutamate function.
    Johnson BA
    CNS Drugs; 2005; 19(10):873-96. PubMed ID: 16185095
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Physio-Pharmacological Role of the NPS/NPSR System in Psychiatric Disorders: A Translational Overview.
    Ghazal P
    Curr Protein Pept Sci; 2016; 17(4):380-97. PubMed ID: 26680586
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Combining treatments for alcoholism: why and how?
    Mattson ME; Litten RZ
    J Stud Alcohol Suppl; 2005 Jul; (15):8-16; discussion 6-7. PubMed ID: 16223051
    [TBL] [Abstract][Full Text] [Related]  

  • 57. What Is Addiction? How Can Animal and Human Research Be Used to Advance Research, Diagnosis, and Treatment of Alcohol and Other Substance Use Disorders?
    Bickel WK; Crabbe JC; Sher KJ
    Alcohol Clin Exp Res; 2019 Jan; 43(1):6-21. PubMed ID: 30371956
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neuropeptide modulation of addiction: Focus on galanin.
    Genders SG; Scheller KJ; Djouma E
    Neurosci Biobehav Rev; 2020 Mar; 110():133-149. PubMed ID: 29949733
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Exploring the Neurochemical Basis of Alcohol Addiction-Related Behaviors: Translational Research.
    Budygin EA; Weiner JL
    Transl Biomed; 2015; 6(Suppl Spec):. PubMed ID: 26770883
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acamprosate: a prototypic neuromodulator in the treatment of alcohol dependence.
    Mason BJ; Heyser CJ
    CNS Neurol Disord Drug Targets; 2010 Mar; 9(1):23-32. PubMed ID: 20201812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.